Oversizing lung allografts deteriorates outcomes in patients with pulmonary fibrosis

BACKGROUND: Lung transplantation is the only curative treatment for patients with end-stage pulmonary fibrosis. Due to the shortage of donor organs most lung allografts are either oversized or undersized. It is still under debate whether over- or undersizing is preferably performed regarding the postoperative outcome. We therefore analysed our data using predicted total lung capacity to compare size-mismatches. METHODS: Patient records were retrospectively reviewed. Three groups were formed, one including patients with a donor-recipients pTLC-ratio (DRPR) of <1.0 (undersized group), the second with a DRPR of

• Franz, M.
• Tavil, S.
• de Manna, N. D.
• Aburahma, K.
• Boethig, D.
• Bobylev, D.
• Welte, T.
• Greer, M.
• Schwerk, N.
• Ruhparwar, A.
• Kuehn, C.
• Salman, J.
• Ius, F.